NanoViricides Revenue and Competitors
Estimated Revenue & Valuation
- NanoViricides's estimated annual revenue is currently $1.1M per year.
- NanoViricides's estimated revenue per employee is $155,000
Employee Data
- NanoViricides has 7 Employees.
- NanoViricides grew their employee count by 0% last year.
NanoViricides's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP R&D | Reveal Email/Phone |
4 | Executive Chairman, President | Reveal Email/Phone |
NanoViricides Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is NanoViricides?
Official LinkedIn Page of NanoViricides, Inc NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against viruses. NanoViricides is a public company, currently trading on the NYSE under the ticker symbol NNVC
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 7 | 0% | N/A |
#2 | $0.5M | 7 | 0% | N/A |
#3 | $2.3M | 14 | -48% | N/A |
#4 | $3.3M | 17 | 21% | N/A |
#5 | $3.1M | 22 | 16% | N/A |